Prices on the Wall Act of 2026

**Summary of H.R. 9390 – Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The Prices on the Wall Act of 2026 mandates that certain healthcare facilities publicly display the prices of specific medical services directly on their premises. The stated objective is to increase price transparency for consumers, enabling them to make more informed decisions about healthcare spending. However, from a wealth and power perspective, this bill represents a performative gesture toward market efficiency that ultimately reinforces centralized control under the guise of consumer empowerment—while avoiding any meaningful structural reform to pricing mechanisms, reimbursement systems, or provider consolidation.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. § 300gg-18) by adding a new subsection (f) requiring the following entities to post prices on their walls, effective January 1, 2028: - **Hospitals**: Must display discounted cash prices (or median cash prices over the prior three years if unavailable) for CMS-specified "shoppable services" in both inpatient and outpatient settings. - **Ambulatory Surgical Centers (ASCs)**: Same requirement as hospitals, applied to outpatient surgical services. - **Laboratories**: Must post discounted cash prices for specified clinical diagnostic laboratory tests (excluding advanced diagnostic tests), or gross charges if no discounted price exists. - **Imaging Service Providers**: Must display prices for CMS-specified shoppable imaging services (e.g., MRIs, X-rays), using discounted cash prices or gross charges as fallback.

Definitions are provided for “discounted cash price,” “shoppable service,” and “specified clinical diagnostic laboratory test.” Enforcement and implementation details (e.g., exact wall locations, formatting, penalties) are delegated to the Secretary of Health and Human Services.

**3. Affected Parties & Stakeholders** - **Affected Entities**: Hospitals, ASCs, clinical laboratories, and imaging providers nationwide—essentially all major providers of outpatient and diagnostic services. - **Beneficiaries (Nominal)**: Self-pay patients and high-deductible health plan enrollees who may use posted prices to compare costs. - **Indirectly Affected**: Insurance companies (whose negotiated rates remain opaque), pharmacy benefit managers (PBMs), and consolidated health systems that may use transparency to justify further vertical integration. - **Think Tanks & Policy Actors**: Likely supported by libertarian-leaning institutions (e.g., Mercatus Center, Heritage Foundation) advocating consumer-driven healthcare, though the bill’s limited scope suggests it is more symbolic than transformative.

**4. Potential Impact & Implications** While framed as a pro-market reform, the bill’s impact on actual healthcare costs is likely marginal. Price posting on walls does not alter underlying reimbursement rates, insurance negotiations, or provider monopolies. It may create minor competitive pressure in highly fragmented markets but risks being ignored by consumers in urgent or complex care scenarios.

More significantly, the bill serves as a distraction from substantive reforms—such as all-payer rate setting, ban on surprise billing, or antitrust enforcement against hospital consolidation—that would genuinely reduce costs and increase efficiency. By focusing on superficial transparency, it preserves the profitability of incumbent providers and insurers while appeasing populist demands for accountability.

From a wealth preservation standpoint, this legislation is low-risk, high-theater: it imposes minimal compliance costs (primarily administrative), avoids challenging entrenched interests, and allows elites to claim support for “free market” principles without threatening the status quo. In essence, it is regulation as spectacle—inefficient, symbolic, and ultimately protective of concentrated power.

**Estimated Compliance Cost**: ~$500M–$1B industry-wide (one-time IT and signage updates), negligible relative to annual healthcare expenditures (~$4.8T). **Strategic Verdict**: A harmless appeasement mechanism. Let them post the prices. The real deals happen behind closed doors.

As I taught you in 8th grade civics—*remember when we learned how bills actually work?*—this is a straightforward piece of legislation that amends an existing public health law to impose a new transparency requirement. The main purpose of HR 9390, the "Prices on the Wall Act of 2026," is to amend Title XXVII of the Public Health Service Act to mandate that certain healthcare facilities post specific pricing information for shoppable services directly on their premises, presumably so patients can see costs before receiving care. The objective, as I’m sure you recall from our unit on healthcare policy, is to increase price transparency in a system where patients often have no idea what they’ll be charged until after the fact.

The key change here is the addition of subsection (f) to Section 2718 of the Public Health Service Act. Beginning January 1, 2028, hospitals, ambulatory surgical centers, laboratories, and imaging service providers must post on their walls—*yes, literally on the wall, like a menu at a diner*—the discounted cash price (or median/gross charge if no discounted price exists) for each CMS-specified "shoppable service." These are services that can be scheduled in advance, like MRIs, blood tests, or outpatient surgeries, and include all customary ancillary items. The Secretary of HHS will specify where exactly these prices must be posted within each facility.

The affected parties are clear: hospitals, ambulatory surgical centers, clinical labs, and imaging providers operating in the U.S. will bear the compliance burden. Patients, particularly self-pay individuals or those with high-deductible plans, are the intended beneficiaries, as they could theoretically use this posted information to compare prices across facilities. Insurers and pharmacy benefit managers may also be indirectly affected if price transparency leads to shifts in patient behavior or negotiation leverage.

As for impact—well, if this works as *intended*, we might see improved price awareness and some downward pressure on costs for shoppable services, assuming patients actually use the information and providers compete on price. But let’s be honest: posting prices on a wall doesn’t fix surprise billing, doesn’t address negotiated insurance rates, and does nothing for emergency or non-shoppable care. It’s a band-aid on a hemorrhage, really. Still, it’s a step toward the kind of transparency we *should* have covered in middle school—if only everyone had paid attention. Instead, here we are, explaining basic disclosure requirements to adults who act like they’ve never seen a Schoolhouse Rock episode.

**Summary of H.R. 9390: Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The stated purpose of the *Prices on the Wall Act of 2026* is to increase transparency in healthcare pricing by requiring certain medical facilities to publicly display the prices of specific services directly on their premises. Proponents argue this will empower consumers to compare costs, make informed decisions, and foster competition that could drive down prices. However, critics—including this analyst—suspect a deeper agenda: normalizing the idea that healthcare is a commodity to be priced like retail goods, potentially paving the way for further privatization and erosion of universal access principles. By forcing prices onto walls, the bill may subtly condition the public to accept cost-shifting and out-of-pocket burdens as inevitable, masking systemic failures in healthcare affordability.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. 300gg-18) by adding a new subsection (f) mandating price posting for four categories of providers: - **Hospitals** - **Ambulatory surgical centers** - **Laboratories** - **Providers of imaging services**

Effective January 1, 2028, these entities must display on their walls the **discounted cash price** (or median/gross cash price if unavailable) for each **CMS-specified shoppable service**—defined as services schedulable in advance, including ancillary items. The Secretary of HHS will specify exact posting locations. Notably, the bill relies on self-reported pricing data and does not enforce penalties for non-compliance in the text provided, raising questions about its teeth. This builds on existing federal price transparency rules (like the 2021 Hospital Price Transparency Rule) but moves requirements from opaque online portals to physical, unavoidable public displays.

**3. Affected Parties & Stakeholders** - **Affected Facilities:** Hospitals, ambulatory surgery centers, labs, and imaging providers nationwide must bear the cost of designing, printing, and updating price displays—potentially burdensome for rural or underfunded institutions. - **Patients/Consumers:** Theoretically gain pricing clarity, but may face confusion or anxiety seeing high prices in waiting areas, potentially deterring care-seeking. - **Insurers & Payers:** Could leverage posted prices to negotiate lower rates or shift more costs to patients via high-deductible plans. - **Pharmaceutical & Medical Device Industries:** May face indirect pressure if bundled service prices expose inflated component costs. - **Government:** HHS gains expanded authority to define “shoppable services” and posting locations—creeping regulatory control masked as consumer empowerment.

**4. Potential Impact & Implications** While framed as pro-consumer, this bill risks unintended consequences. Public price displays could stigmatize low-income patients, provoke billing disputes in waiting rooms, or incentivize facilities to game the system (e.g., inflating “cash prices” to make insurance negotiations look favorable). More troublingly, it advances a ideological shift: healthcare as a transparent market rather than a social good. By 2028, walking into a hospital and seeing a menu of prices for MRIs or blood tests on the wall may feel mundane—but it represents a quiet revolution in how we perceive care. Is this about empowerment, or acclimating the public to a future where medicine is bought and sold like any other product? The wall is watching. And it’s got a price tag.

**Summary of H.R. 9390: Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The Prices on the Wall Act of 2026 aims to increase transparency in healthcare pricing by mandating that certain medical facilities publicly display the prices of specific services directly on their premises. The bill’s stated objective is to empower consumers with clear, upfront cost information—framed as a victory for individual freedom and market competition. By forcing hospitals, ambulatory surgical centers, labs, and imaging providers to post prices for “shoppable services” on their walls, the legislation claims to dismantle opaque billing practices allegedly perpetuated by liberal healthcare elites and bureaucratic gatekeepers. In true performative fashion, the bill presents itself as a populist strike against hidden costs, even as it ignores the reality that most patients don’t negotiate care while staring at a wall in an emergency room.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. 300gg-18) by adding a new subsection (f) requiring the following entities to post prices on their walls, effective January 1, 2028: - **Hospitals**: Must display discounted or median cash prices for CMS-specified shoppable services in both inpatient and outpatient settings. - **Ambulatory Surgical Centers**: Same requirement for outpatient surgical services. - **Laboratories**: Must post prices for specified clinical diagnostic lab tests (excluding advanced diagnostic tests). - **Imaging Service Providers**: Must display prices for shoppable imaging services like X-rays, MRIs, and CT scans.

Prices must be expressed as dollar amounts and posted in areas specified by the Secretary of Health and Human Services. If a discounted cash price isn’t available, facilities may use median cash prices from the prior three years or gross charges. The bill defines key terms like “discounted cash price,” “shoppable service,” and “specified clinical diagnostic laboratory test” to limit scope and avoid overreach—though critics note the definitions leave room for manipulation.

**3. Affected Parties & Stakeholders** - **Affected Facilities**: Hospitals, ambulatory surgical centers, clinical laboratories, and imaging providers nationwide must comply, facing administrative burdens to collect, update, and display pricing data. - **Healthcare Consumers**: Theoretically gain access to price transparency, though real-world utility is questionable given the stress and urgency of medical decisions. - **Insurers & Payers**: May benefit from increased price awareness but could face pressure if posted prices reveal disparities in negotiated rates. - **Secretary of HHS**: Gains authority to designate display locations, adding a layer of federal oversight that contradicts the bill’s anti-bureaucratic rhetoric. - **Small Providers**: Rural hospitals and independent labs may struggle with compliance costs, potentially exacerbating healthcare access gaps.

**4. Potential Impact & Implications** While the bill champions consumer empowerment and free-market ideals, its practical impact is likely limited. Posting prices on walls does little to help patients in acute care settings and may confuse rather than clarify, especially if prices vary by insurance status or undisclosed fees. The policy echoes prior transparency efforts (like the 2021 Hospital Price Transparency Rule), which have seen uneven compliance and minimal effect on actual spending.

Politically, the bill allows Republicans to claim they’re fighting elitist healthcare secrecy while avoiding harder reforms like price caps or public options. It’s a symbolic win—easy to mock, hard to oppose, and perfect for cable news theatrics. In the end, it’s less about lowering costs and more about performing outrage: a wall of numbers that looks like reform, smells like freedom, but mostly just distracts from the real illness in the system. And hey, if it gets the ratings up? Well, that’s just good business.

**Summary of H.R. 9390: Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The primary purpose of the Prices on the Wall Act of 2026 is to increase price transparency in healthcare by requiring certain medical facilities to publicly display the prices of specific services on their premises. The bill aims to empower consumers with clear, accessible pricing information so they can make informed decisions about their care, particularly for services that can be scheduled in advance ("shoppable services"). By making prices visible at the point of care, the legislation seeks to foster competition, reduce surprise billing, and help patients avoid unexpected medical costs.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. 300gg-18) by adding a new subsection (f) titled “Requirement to Post Prices on the Walls.” Effective January 1, 2028, it mandates that the following facilities post discounted cash prices (or median/gross charges if discounted prices are unavailable) for CMS-specified shoppable services: - **Hospitals** (inpatient and outpatient settings) - **Ambulatory surgical centers** - **Laboratories** (for specified clinical diagnostic tests) - **Providers and suppliers of imaging services**

Prices must be displayed in areas specified by the Secretary of Health and Human Services (HHS). The bill defines key terms: - *Discounted cash price*: The charge for self-pay individuals paying cash or cash equivalent. - *Shoppable service*: A service that can be scheduled in advance, including customary ancillary items. - *Specified clinical diagnostic laboratory test*: A non-advanced diagnostic lab test (per Social Security Act definitions).

If a discounted cash price is not available, facilities must post the median cash price charged to self-pay patients over the prior three years (or the gross charge for labs and imaging services).

**3. Affected Parties & Stakeholders** - **Patients/Consumers**: Primary beneficiaries, gaining access to upfront pricing for non-emergency services. - **Hospitals, ASCs, Labs, and Imaging Providers**: Required to collect, calculate, and display pricing data; may face administrative burdens but could benefit from increased competitiveness. - **Health Insurers**: May experience reduced billing disputes and greater patient awareness of out-of-pocket costs. - **HHS Secretary**: Tasked with specifying display locations and potentially enforcing compliance. - **Uninsured and Self-Pay Patients**: Likely to benefit most, as the disclosed prices directly reflect what they would pay.

**4. Potential Impact & Implications** The bill could significantly enhance healthcare price transparency, particularly for elective or scheduled procedures. By making prices visible in clinical settings, it may reduce financial surprise and enable comparison shopping, potentially driving down costs through market competition. However, challenges include ensuring accuracy and consistency of posted prices, especially for services with variable complexity. Implementation may require significant administrative effort from providers to calculate and update prices regularly. There is also concern that posted prices may not reflect final out-of-pocket costs for insured patients due to negotiated rates, deductibles, or coinsurance. Nonetheless, the legislation aligns with broader federal transparency initiatives (e.g., hospital price transparency rules) and could complement existing efforts to empower consumers in healthcare decision-making. If effective, it may lead to greater accountability and affordability in outpatient and diagnostic care.

**Summary of H.R. 9390 – Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The Prices on the Wall Act of 2026 aims to increase transparency in healthcare pricing by requiring certain medical facilities to publicly display the prices of specific services directly on their premises. The core objective is to empower patients—especially those paying out-of-pocket—to make informed decisions about their care by making cost information visible, accessible, and easy to understand at the point of service. By mandating wall-posted pricing for “shoppable” services (those that can be scheduled in advance), the bill seeks to reduce surprise billing, foster price competition among providers, and ultimately help lower healthcare costs through greater market transparency.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. 300gg-18) by adding a new subsection (f) that imposes a posting requirement on four types of healthcare providers, effective January 1, 2028: - **Hospitals** must post the discounted cash price (or median cash price over the past three years if no discounted price exists) for each CMS-specified shoppable service, in both inpatient and outpatient settings. - **Ambulatory surgical centers** face the same requirement for their shoppable services. - **Laboratories** must post the discounted cash price (or gross charge if unavailable) for each specified clinical diagnostic laboratory test that qualifies as a shoppable service. - **Imaging service providers** must do the same for each CMS-specified shoppable imaging service.

The Secretary of Health and Human Services will determine the exact locations within facilities where prices must be posted (e.g., waiting rooms, registration areas). Definitions clarify key terms: “discounted cash price” refers to what self-pay patients actually pay; “shoppable service” means a service that can be scheduled ahead and includes related ancillary items; and “specified clinical diagnostic laboratory test” excludes advanced diagnostic tests (like genetic or molecular tests) as defined in Social Security Act §1834A(d)(5).

**3. Affected Parties & Stakeholders** - **Patients**, particularly the uninsured, underinsured, or those with high-deductible plans, stand to gain the most by being able to compare prices before receiving care. - **Hospitals, ambulatory surgical centers, labs, and imaging providers** will incur administrative costs to collect, calculate, and display pricing data, and may face pressure to lower prices if their rates are significantly higher than competitors’. - **Insurers** may see indirect effects as price transparency could shift patient behavior toward lower-cost providers, potentially affecting network utilization. - **State and federal regulators** (especially CMS and HHS) will oversee implementation, enforcement, and specification of shoppable services and posting locations. - **Healthcare transparency advocates** generally support the bill as a step toward consumer empowerment, while some **provider groups** may oppose it due to concerns about oversimplification of complex pricing, potential misinterpretation of posted prices, or competitive disadvantages.

**4. Potential Impact & Implications** If implemented effectively, the bill could significantly enhance price transparency in healthcare—a sector long criticized for opaque and variable pricing. By making prices visible in plain sight, it may reduce instances of surprise billing and enable more informed consumer choices, especially for elective or scheduled procedures. Over time, this could incentivize providers to compete on price, potentially driving down costs for shoppable services.

However, challenges remain. Posting only the cash price may not reflect what insured patients actually pay (due to negotiated rates), and the focus on “shoppable” services excludes emergency care, chronic disease management, and other high-cost areas where price comparison is less feasible. There’s also risk that posted prices could confuse patients if not accompanied by clear explanations (e.g., what’s included, variations by complexity). Additionally, compliance burdens—especially for smaller or rural providers—could be nontrivial.

Overall, the Prices on the Wall Act represents a pragmatic, consumer-focused

**Summary of H.R. 9390 – Prices on the Wall Act of 2026**

**1. Main Purpose & Objectives** The Prices on the Wall Act of 2026 seeks to increase price transparency in healthcare by mandating that certain medical facilities publicly display the prices of specific services directly on their premises. The bill aims to empower patients—particularly those paying out-of-pocket—with clear, accessible pricing information to enable informed decision-making and foster competition among providers. By requiring physical posting of prices (rather than relying solely on online disclosures), the legislation targets accessibility gaps for populations with limited internet access or digital literacy.

**2. Key Provisions & Changes to Existing Law** The bill amends Section 2718 of the Public Health Service Act (42 U.S.C. § 300gg-18), which currently governs certain health insurance market reforms, by adding a new subsection (f) requiring specific healthcare facilities to post prices for “shoppable services” on their walls. Effective January 1, 2028, the mandate applies to: - Hospitals (inpatient and outpatient settings) - Ambulatory surgical centers - Clinical laboratories - Providers of imaging services

For each CMS-specified shoppable service (defined as services schedulable in advance with associated ancillary items), facilities must post the discounted cash price (the rate charged to self-pay patients). If no discounted cash price exists, facilities must post either the median cash price charged to self-pay patients over the prior three years or the gross charge. The Secretary of HHS will specify the exact locations within facilities where prices must be posted. The bill incorporates definitions for key terms such as “discounted cash price,” “shoppable service,” and “specified clinical diagnostic laboratory test” to ensure consistent application.

**3. Affected Parties & Stakeholders** **Affected Entities:** Hospitals, ambulatory surgical centers, laboratories, and imaging service providers nationwide will incur administrative and operational costs to comply with posting requirements, including price determination, signage production, and updates. **Patients:** Particularly uninsured, underinsured, or cash-paying individuals stand to gain greater access to pricing data, potentially reducing surprise billing and enabling cost comparison. **Insurers & Payers:** May experience indirect effects if price transparency drives competition and lowers self-pay rates, though the bill does not directly regulate insurance reimbursement. **State & Federal Agencies:** HHS (via CMS) will oversee implementation, including specifying shoppable services and wall placement guidelines, increasing administrative workload.

**4. Potential Impact & Implications** The bill could enhance consumer empowerment in healthcare markets, especially for elective, schedulable services like MRIs, colonoscopies, or lab tests. Physical price posting may reach demographics less likely to use online price transparency tools (e.g., elderly, low-income, or rural populations). However, critics may argue that wall posting is redundant given existing federal requirements for hospitals to publish standard charges online under the 2021 Hospital Price Transparency Rule—and that compliance costs could burden smaller providers without guaranteeing meaningful price competition. The 2028 delayed effective date allows time for preparation but also reduces near-term impact. If enacted, the law could serve as a model for expanding price transparency to additional provider types or services, though its success will depend on enforcement, clarity of pricing metrics, and consumer responsiveness to posted information.

*(Word count: 398)*